Hartkopf, A. D., Huober, J., Volz, B., Nabieva, N., Taran, F., Schwitulla, J., Overkamp, F., Kolberg, H., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lux, M. P., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wimberger, P., Hielscher, C., Geberth, M., Fersis, N., Abenhardt, W., Kurbacher, C., Wuerstlein, R., Thomssen, C., Untch, M., Fasching, P. A., Janni, W., Fehm, T. N., Wallwiener, D., Brucker, S. Y., & Schneeweiss, A. (2018). treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry. Breast, 37, 42–51. http://access.bl.uk/ark:/81055/vdc_100054582640.0x000029